Skip to content

Durability of Two Skin Barrier Protectants (SBP)

An Evaluation of the Skin Protection Characteristics of Two Commercially Available Skin Barrier Protectants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05756348
Enrollment
42
Registered
2023-03-06
Start date
2022-10-06
Completion date
2022-11-22
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Hydration in Healthy Volunteers

Brief summary

The current study will evaluate the duration of wear and durability of two commercially available SBPs: Medline Marathon® XL (extra long) No Sting Cyanoacrylate Skin Protectant (henceforth referred to as Marathon®) and 3M™ Cavilon™ Advanced Skin Protectant (henceforth referred to as Cavilon™).

Detailed description

Completion of informed consent and participant screening will be followed by a washout period of minimum 18 hours (wherein participants will be asked to avoid application of cleansers, lotions, or perfumes to both forearms and inner elbows) prior to the first visit (Visit 1) of the study. During Visit 1, study personnel will confirm that the washout period has been successfully completed. Participants will wash their forearms and inner elbows with a standardized soap and dry them using paper towels for each arm. After the participants' forearms and inner elbows have fully dried, study personnel will use a Corneometer® (which measures skin hydration) to record baseline measurements of the skin within 2-inch x 2-inch squares (starting about two inches above the wrist) marked with a non-toxic marker on the volar forearms and inner elbows of the participants. Thereafter, participants will be randomized to the two SBPs, Marathon® or Cavilon™ (designated SBP). The designated SBP will be applied to the volar forearm and inner elbow test areas on the participant's dominant arm (as determined by the participant). The other SBP will be applied to the volar forearm and inner elbow test areas on the participant's non-dominant arm. A distinct area of each volar forearm will be used as an untreated control area. Corneometer® measurements will be taken again on the same day after the SBPs have been left to dry for at least one minute or have fully dried. Thereafter, subsequent measurements will be taken daily over a seven-day period with a two-day break over the weekend. Each participant will commence the study on Monday or Tuesday. This will permit daily readings for the first 72 hours, which is the more important window to evaluate SBP wear time. There will be a two-day break in measurements over the weekend, after which Corneometer® measurements will be taken either on Monday, or Monday and Tuesday, depending on the participants' start date. Participants will be allowed to bathe their arms using a standardized soap provided by the study personnel but will be asked to minimize scrubbing and any other abrasion of the volar forearms and inner elbows. In addition, participants will be instructed not to engage in activities, for eg, sports (eg, tennis) or holding a baby that may cause significant abrasion on one arm and not the other. On the last visit of the study (Visit 6), study personnel will take the last set of Corneometer® measurements. In addition, participants will also complete surveys regarding their experience with the SBPs on specific days during study participation. The Corneometer® measurements will help determine the presence of the SBPs and their deterioration over time. Skin treated with the SBPs will typically have lower readings than untreated skin. As the SBPs break down, the corresponding readings are expected to rise.

Interventions

DEVICEMarathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant

All participants will receive both device interventions listed above.

Sponsors

Medline Industries
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals ≥ 18 years of age

Exclusion criteria

* Individuals have skin conditions that might interfere with Corneometer® measurements, including rash, irritation, sunburn, tattoo, birthmark, any other dermal irregularities on the left or right volar forearm or inner elbow. * Individuals have excessive hair on the left or right volar forearm or inner elbow as determined by study personnel. * Individuals have a self-reported allergy/sensitivity to ingredients present in either of the SBPs, components of the soap used for bathing, or the exam gloves and non-toxic marker used in the study. * Individuals are pregnant. * Individuals whose self-reported activities may affect friction on one arm more than the other (eg, sports like tennis or holding a baby where one arm is used more routinely than the other). * Individuals who are able to identify the manufacturer of the SBPs included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Duration7 Days - Baseline + 6 visits = 7To evaluate the duration of wear of Marathon® and Cavilon™ using the Corneometer® CM (capacitance method) 825 taking measurements of the skin (in Arbitrary Units) with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.
Durability7 Days - Baseline + 6 visits = 7To evaluate the durability of Marathon® and Cavilon™ using the Corneometer® CM 825 taking measurements of the skin (in Arbitrary Units) in the inner elbow location with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.

Secondary

MeasureTime frameDescription
Participant Feedback 21 dayTo collect information on the participant experience with the two SBPs (Skin Barrier Protectants) using survey results (5 point scale from very comfortable to very uncomfortable). This question was on assessed at visit one.
Participant Feedback2 DaysTo collect information on the participant experience with the two SBPs using survey results (yes/no questions). This measurement collected on visit thee and visit six.
Participant Feedback - Product Preference7 Days - Baseline + 6 visits = 7Collect participant feedback on which arm is it easier to determine the skin barrier protectant is present?

Countries

United States

Participant flow

Pre-assignment details

All participants received both the Medline and Cavilon products. Analysis was performed per product not per arm randomization. The dominant arm of participants was randomized to receive one intervention (i.e., Marathon® or Cavilon™ ), and the non-dominant arm received the other intervention.

Participants by arm

ArmCount
All Participants
all participants receive both products under evaluation. Marathon® XL No Sting Cyanoacrylate Skin Protectant and 3M™ Cavilon™ Advanced Skin Protectant: All participants will receive both device interventions listed above.
42
Total42

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
Fitzpatrick Skin Assessment Scale
II (fair)
15 Participants
Fitzpatrick Skin Assessment Scale
III (medium)
20 Participants
Fitzpatrick Skin Assessment Scale
I (very fair)
1 Participants
Fitzpatrick Skin Assessment Scale
IV (olive)
5 Participants
Fitzpatrick Skin Assessment Scale
V (brown)
1 Participants
Fitzpatrick Skin Assessment Scale
VI (dark brown)
0 Participants
Race and Ethnicity Not Collected— Participants
Sex/Gender, Customized
Decline to Answer
1 Participants
Sex/Gender, Customized
Female
21 Participants
Sex/Gender, Customized
Male
20 Participants
Sex/Gender, Customized
Other
0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 420 / 42
other
Total, other adverse events
0 / 420 / 42
serious
Total, serious adverse events
0 / 420 / 42

Outcome results

Primary

Durability

To evaluate the durability of Marathon® and Cavilon™ using the Corneometer® CM 825 taking measurements of the skin (in Arbitrary Units) in the inner elbow location with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.

Time frame: 7 Days - Baseline + 6 visits = 7

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsDurabilityCavilon Visit 42.72 percent changeStandard Deviation 6.23
All ParticipantsDurabilityMarathon Visit 32.10 percent changeStandard Deviation 5.27
All ParticipantsDurabilityMarathon Visit 03.00 percent changeStandard Deviation 4.33
All ParticipantsDurabilityCavilon Visit 04.49 percent changeStandard Deviation 6.14
All ParticipantsDurabilityMarathon Visit 11.37 percent changeStandard Deviation 5.11
All ParticipantsDurabilityCavilon Visit 12.70 percent changeStandard Deviation 6.01
All ParticipantsDurabilityMarathon Visit 2-0.59 percent changeStandard Deviation 4.11
All ParticipantsDurabilityCavilon Visit 22.53 percent changeStandard Deviation 5.93
All ParticipantsDurabilityCavilon Visit 32.65 percent changeStandard Deviation 4.68
All ParticipantsDurabilityMarathon Visit 45.10 percent changeStandard Deviation 6.71
All ParticipantsDurabilityMarathon Visit 57.21 percent changeStandard Deviation 7.45
All ParticipantsDurabilityCavilon Visit 52.32 percent changeStandard Deviation 6.86
All ParticipantsDurabilityMarathon Visit 68.50 percent changeStandard Deviation 7.02
All ParticipantsDurabilityCavilon Visit 64.25 percent changeStandard Deviation 6.46
Primary

Duration

To evaluate the duration of wear of Marathon® and Cavilon™ using the Corneometer® CM (capacitance method) 825 taking measurements of the skin (in Arbitrary Units) with the skin protectant applied at various time points compared to the skin control site without skin protectant at the same time points.

Time frame: 7 Days - Baseline + 6 visits = 7

Population: Low arbitrary units correlate with less moisture (better skin protectant). As skin protectant wears off, arbitrary units will increase over time indicating duration of wear of skin protectant.

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsDurationCavilon Follow-up 217.00 arbitrary unitsStandard Deviation 6.06
All ParticipantsDurationMarathon Follow-up 315.71 arbitrary unitsStandard Deviation 7.73
All ParticipantsDurationMarathonFollow-up 626.99 arbitrary unitsStandard Deviation 8.82
All ParticipantsDurationCavilon Follow-up 623.96 arbitrary unitsStandard Deviation 10.06
All ParticipantsDurationMarathon Baseline 036.71 arbitrary unitsStandard Deviation 9.99
All ParticipantsDurationCavilon Baseline 036.31 arbitrary unitsStandard Deviation 1.6
All ParticipantsDurationMarathon Follow-up 17.95 arbitrary unitsStandard Deviation 5.31
All ParticipantsDurationCavilon Follow-up 120.98 arbitrary unitsStandard Deviation 1.34
All ParticipantsDurationMarathon Follow-up 29.58 arbitrary unitsStandard Deviation 7.8
All ParticipantsDurationCavilon Follow-up 317.67 arbitrary unitsStandard Deviation 5.68
All ParticipantsDurationMarathon Follow-up 420.23 arbitrary unitsStandard Deviation 9.18
All ParticipantsDurationCavilon Follow-up 419.2 arbitrary unitsStandard Deviation 7.82
All ParticipantsDurationMarathon Follow-up 523.07 arbitrary unitsStandard Deviation 10.66
All ParticipantsDurationCavilon Follow-up 522.51 arbitrary unitsStandard Deviation 9.16
Secondary

Participant Feedback

To collect information on the participant experience with the two SBPs using survey results (yes/no questions). This measurement collected on visit thee and visit six.

Time frame: 2 Days

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
All ParticipantsParticipant FeedbackCavilon Visit 6: Did the SBP accumulate dirt or debris?yes20 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Did the SBP adhere to clothing or material?no34 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Do you see the SBP on your skin?yes36 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Do you see the SBP on your skin?no6 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Do you see the SBP on your skin?yes37 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Do you see the SBP on your skin?no5 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Did the SBP accumulate dirt or debris?yes10 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Did the SBP accumulate dirt or debris?no32 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Did the SBP accumulate dirt or debris?yes20 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Did the SBP accumulate dirt or debris?no22 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Did the SBP adhere to clothing or material?yes8 Participants
All ParticipantsParticipant FeedbackMarathon Visit 3: Did the SBP adhere to clothing or material?no34 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Did the SBP adhere to clothing or material?yes19 Participants
All ParticipantsParticipant FeedbackCavilon Visit 3: Did the SBP adhere to clothing or material?no23 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Do you see the SBP on your skin?yes37 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Do you see the SBP on your skin?no5 Participants
All ParticipantsParticipant FeedbackCavilon Visit 6: Do you see the SBP on your skin?yes36 Participants
All ParticipantsParticipant FeedbackCavilon Visit 6: Do you see the SBP on your skin?no6 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Did the SBP accumulate dirt or debris?yes10 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Did the SBP accumulate dirt or debris?no32 Participants
All ParticipantsParticipant FeedbackCavilon Visit 6: Did the SBP accumulate dirt or debris?no22 Participants
All ParticipantsParticipant FeedbackMarathon Visit 6: Did the SBP adhere to clothing or material?yes8 Participants
All ParticipantsParticipant FeedbackCavilon Visit 6: Did the SBP adhere to clothing or material?yes19 Participants
All ParticipantsParticipant FeedbackCavilon Visit 6: Did the SBP adhere to clothing or material?no23 Participants
Secondary

Participant Feedback 2

To collect information on the participant experience with the two SBPs (Skin Barrier Protectants) using survey results (5 point scale from very comfortable to very uncomfortable). This question was on assessed at visit one.

Time frame: 1 day

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
All ParticipantsParticipant Feedback 2Marathon Visit 1: Is the SBP comfortable on your armVery Comfortable3 Participants
All ParticipantsParticipant Feedback 2Marathon Visit 1: Is the SBP comfortable on your armComfortable10 Participants
All ParticipantsParticipant Feedback 2Marathon Visit 1: Is the SBP comfortable on your armNeutral11 Participants
All ParticipantsParticipant Feedback 2Marathon Visit 1: Is the SBP comfortable on your armUncomfortable18 Participants
All ParticipantsParticipant Feedback 2Marathon Visit 1: Is the SBP comfortable on your armVery Uncomfortable0 Participants
All ParticipantsParticipant Feedback 2Cavilon Visit 1: Is the SBP comfortable on your armVery Comfortable8 Participants
All ParticipantsParticipant Feedback 2Cavilon Visit 1: Is the SBP comfortable on your armComfortable25 Participants
All ParticipantsParticipant Feedback 2Cavilon Visit 1: Is the SBP comfortable on your armNeutral6 Participants
All ParticipantsParticipant Feedback 2Cavilon Visit 1: Is the SBP comfortable on your armUncomfortable2 Participants
All ParticipantsParticipant Feedback 2Cavilon Visit 1: Is the SBP comfortable on your armVery Uncomfortable1 Participants
Secondary

Participant Feedback - Product Preference

Collect participant feedback on which arm is it easier to determine the skin barrier protectant is present?

Time frame: 7 Days - Baseline + 6 visits = 7

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
All ParticipantsParticipant Feedback - Product PreferenceMarathon7 Participants
All ParticipantsParticipant Feedback - Product PreferenceCavilon35 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026